Login to Your Account



'Warm Base' Contract Still Pending

Acambis Gets $30M Vaccine Order, Settles With Novartis

By Randall Osborne


Thursday, September 14, 2006
With a decision due from the FDA early next year on its ACAM2000 smallpox vaccine, Acambis plc took an order from the feds for 10 million more doses at a price of about $30 million, and disclosed separately that $19 million is due from Novartis AG to settle the dispute over another vaccine. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription